Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Cash & Current Investments (2017 - 2025)

Historic Cash & Current Investments for Dr Reddys Laboratories (RDY) over the last 17 years, with Q4 2025 value amounting to $212.4 million.

  • Dr Reddys Laboratories' Cash & Current Investments changed N/A to $212.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $212.4 million, marking a year-over-year change of. This contributed to the annual value of $678.0 million for FY2025, which is 3060.39% down from last year.
  • As of Q4 2025, Dr Reddys Laboratories' Cash & Current Investments stood at $212.4 million.
  • Over the past 5 years, Dr Reddys Laboratories' Cash & Current Investments peaked at $81662.2 billion during Q2 2022, and registered a low of $78.4 million during Q4 2022.
  • Moreover, its 5-year median value for Cash & Current Investments was $196.8 million (2022), whereas its average is $4537.1 billion.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first surged by 6729351493.73% in 2022, then plummeted by 9999.99% in 2023.
  • Quarter analysis of 5 years shows Dr Reddys Laboratories' Cash & Current Investments stood at $317.3 million in 2021, then crashed by 75.28% to $78.4 million in 2022, then grew by 0.4% to $78.8 million in 2023, then increased by 13.81% to $89.6 million in 2024, then skyrocketed by 136.99% to $212.4 million in 2025.
  • Its Cash & Current Investments stands at $212.4 million for Q4 2025, versus $199.8 million for Q3 2025 and $170.5 million for Q2 2025.